Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Micromet, Inc. (MITI)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: MITI
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Sep 11
•
Justin M. Hall
•
ALTH
,
ARIA
,
ARQL
•
23 Comments
'When There's Blood in the Streets', Buy Biotech Stocks
Oct 10, 2008
•
Ohad Hammer
•
ALNY
,
ALTH
,
AMGN
•
13 Comments
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
ABPI
,
AFFY
,
AGEN
•
7 Comments
Micromet: More Reasons for Optimism
May 11
•
Ohad Hammer
•
ARQL
,
EXEL
,
IBB
•
7 Comments
Micromet: Another Seal of Approval
Aug 21, 2008
•
Ohad Hammer
•
MITI
•
6 Comments
Immunogen and Seattle Genetics: Verging on an Inflection Point
May 27, 2008
•
Ohad Hammer
•
CRGN
,
DNA
,
IMGN
•
4 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Sep 20
•
Justin M. Hall
•
AGN
,
ALTH
,
ARIA
•
3 Comments
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
ABPI
,
ACEL
,
AFFY
•
3 Comments
Bright Prospects for Micromet (Part 2)
Apr 24
•
Ohad Hammer
•
IMGN
,
MEDX
,
MITI
•
3 Comments
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
ABPI
,
ACEL
,
AFFY
•
3 Comments
Top Biotech Picks for ASCO 2009 (Part II)
May 27
•
Ohad Hammer
•
ARQL
,
CRGN
,
EXEL
•
2 Comments
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
ABPI
,
ACEL
,
AFFY
•
1 Comment
FDA Calendar Updates: Keryx Biopharma Announces Phase 2 Results
Jun 9
•
Mike Havrilla
•
ARNA
,
DYAX
,
GSK
•
1 Comment
Cancer Stocks: Lagging Again
Jul 16, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
AMGN
•
1 Comment
Biotech Discounts Galore
Aug 9
•
The Burrill Report
•
ANSV
,
ARIA
,
HGSI
•
1 Comment
Micromet: Biting Cancer
Feb 6, 2008
•
Ohad Hammer
•
IMGN
,
MITI
,
SGEN
•
1 Comment
2009: Positive Outlook for Biotech
Jan 8
•
Michael Becker
•
AMGN
,
ARQL
,
CBST
•
1 Comment
Bullish Thesis for Biotech Remains Intact
Feb 5
•
Michael Becker
•
ALPMF.PK
,
ANDS
,
BMRN
•
1 Comment
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
ABPI
,
ACEL
,
AFFY
•
1 Comment